Peter Buhl

Largest profit: Allarity Therapeutics Denmark ApS (2017) '0 DKK

Most equity: SYMBION A/S (2017) '126,258 DKK

Biggest loss: Allarity Therapeutics Europe ApS (2017) '-63,719 DKK

• Allarity Therapeutics Denmark ApS

  Active

  
  

  Board member (2017-02-13 - 2018-12-11)

• SYMBION A/S

  Active

  
  

  Board member (2010-05-17 - present)

• RHOVAC ApS

  Active

  
  

  Director (2023-01-24 - present)

• VECATA EJENDOMME A/S

  Active

  
  

  Board member (2008-11-19 - 2012-05-01)

• Allarity Therapeutics Europe ApS

  Active

  
  

  Director (2012-08-01 - 2019-09-30)